What fasteris does

Fasteris is the commercial brand of Genesupport SA, a Swiss biotechnology company headquartered in Plan-les-Ouates, Geneva. Founded in 2003, the company operates a laboratory service business focused on next-generation sequencing (NGS) and Sanger sequencing for life science researchers, biotechnology companies, and clinical laboratories. Its customer base spans academic research groups, biotech drug discovery and development programs, and healthcare/clinical laboratory customers needing precision medicine and diagnostic-grade sequencing.

The company's service portfolio is organized across two technology stacks — NGS and Sanger — with NGS offerings covering Ready-to-Run Sequencing, RNA-sequencing (RNA-seq), DNA-sequencing (DNA-Seq), Whole Exome Sequencing (WES), and Custom Projects. Sequencing is performed on Illumina and Ion Torrent platforms, and the workflow is extended by two ancillary modules: Extraction services for sample preparation and Bioinformatics services for both standard and custom computational analysis of NGS data. Fasteris claims early-pioneer positioning in NGS technology and holds patents (filed/pending) related to sequencing methods and workflows under the Genesupport umbrella.

Commercially, Fasteris operates a fee-for-service, project-based laboratory services model. Customers submit biological samples via a dedicated sample shipment portal, and pricing is provided on a quote basis rather than published rates. The go-to-market is sales-led and emphasizes scientific credibility through publications, presentations, conferences, press coverage, and customer newsletters rather than digital or paid acquisition. The company operates as a subsidiary of the privately held Swiss parent Genesupport, with no disclosed external funding, M&A activity, or public listing.

Name

fasteris

Legal name

Genesupport SA

Website

https://fasteris.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

Fasteris is the commercial brand of Swiss biotech Genesupport SA, providing next-generation sequencing and Sanger sequencing laboratory services to academic researchers, biotech companies, and clinical laboratories from its Plan-les-Ouates, Geneva facility.

Ownership category

akta.pro rank

Product category

Genomic Sequencing Services

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industries

Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• DNA sequencing services
• Next-generation sequencing
• Sanger sequencing
• Bioinformatics analysis
• Genomic laboratory services

Headquarters

HQ city

Plan-les-ouates

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Laboratory Sequencing Services: Fee-for-service laboratory operations providing NGS and Sanger sequencing services to life science researchers and biotech companies. Revenue generated through project-based service contracts where customers submit biological samples for sequencing and analysis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Fasteris is a Swiss laboratory service provider that runs customer biological samples through next-generation sequencing (NGS) on Illumina and Ion Torrent platforms and Sanger sequencing instruments, then returns sequence data and/or processed bioinformatics results. Its service portfolio spans standard ready-to-run sequencing, RNA-seq, DNA-seq, whole exome sequencing, custom NGS projects, Sanger standard and custom services, with supporting extraction and bioinformatics analysis as part of an end-to-end workflow.

Product overview

Fasteris operates as a LifeScience provider offering a unified portfolio of sequencing services organized around two primary technology platforms: NGS (Next-Generation Sequencing) and Sanger sequencing. The NGS offering includes Ready-to-Run Sequencing, RNA-sequencing, DNA-sequencing, and Whole Exome Sequencing as core sequencing services, supplemented by Custom projects for bespoke study designs. Two supporting add-on modules—Bioinformatics services and Extraction services—provide end-to-end workflow capability from sample preparation through data analysis. The Sanger branch provides Standard and Custom DNA sequencing services for validation applications. The company positions itself as a pioneer in NGS technology, serving primarily life science and biotech research clients through its Swiss-based operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Ready-to-Run Sequencing Pre-configured sequencing service providing rapid turnaround on Illumina and Ion Torrent platforms for standardized genomic analysis workflows, targeted at researchers needing fast, standardized NGS results.
• RNA-sequencing (RNA-seq) Comprehensive RNA sequencing service enabling gene expression profiling and transcriptomic analysis on Illumina sequencing platforms, targeted at researchers running gene expression and transcriptome studies.
• DNA-sequencing (DNA-Seq) DNA sequencing service covering a range of biological queries including whole genome and targeted sequencing approaches, used by researchers for general genomic analysis.
• Whole Exome Sequencing (WES) Targeted exome sequencing service that captures and sequences all protein-coding regions of the genome to support variant discovery studies, used by clinical and translational researchers.
• Custom projects Tailored NGS solutions for ad-hoc studies requiring non-standard experimental designs or specialized analysis workflows, used by researchers and biotech teams with bespoke sequencing needs.
• Bioinformatics services Computational analysis services supporting both standard pipelines and custom bioinformatics workflows for NGS data interpretation, used by researchers needing expert analysis of sequencing outputs.
• Extraction services DNA and RNA extraction services that prepare high-quality biological samples for downstream sequencing applications, used by researchers submitting samples for sequencing.
• Sanger Standard Services Standard DNA Sanger sequencing services for routine validation and confirmation of genetic sequences, used by researchers for low-throughput verification work.
• Sanger Custom Services Customized DNA Sanger sequencing solutions for specialized validation requirements outside standard service parameters, used when standard Sanger workflows do not fit the project.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Macrogen: Korea-headquartered genomics services company offering Sanger, NGS, and bioinformatics with European operations. Competes head-to-head with Fasteris for academic and biotech sequencing projects, particularly for European and international clients.
• GENEWIZ (Azenta Life Sciences): Now part of Azenta, GENEWIZ is a global genomics services provider with strong Sanger and NGS offerings, bioinformatics, and direct customer submission portals that closely mirror Fasteris' service model.
• CeGaT: Tübingen-based German provider of clinical and research NGS services, including WES, WGS, RNA-seq, and bioinformatics interpretation. A near-twin to Fasteris in service mix and European clinical/research orientation, with similar mid-sized scale.
• Novogene: Global NGS service provider offering DNA-seq, RNA-seq, WES, WGS, and bioinformatics on Illumina platforms. Closest direct competitor to Fasteris in fee-for-service genomics, but at significantly larger scale and broader geographic reach.
• Atlas Biolabs: Berlin-based genomics services company offering DNA-seq, RNA-seq, WES, and bioinformatics for academic and clinical customers. Direct competitor in the DACH/European region with a comparable boutique service profile.

Broad incumbents

• BGI Genomics: One of the world's largest genomics service providers with NGS, WGS, and clinical sequencing capacity. Competes with Fasteris for large international projects while also operating proprietary platforms (e.g., DNBSEQ), giving it strategic independence Fasteris lacks.
• Eurofins Genomics: Subsidiary of Eurofins Scientific, offering a broad portfolio of sequencing, genotyping, and oligo services across Europe and globally. Overlaps directly with Fasteris but benefits from group-scale infrastructure and a much wider commercial footprint.
• Illumina (Services): Dominant NGS instrument vendor whose sequencing services and Connected Software extend into service-provider territory. Not a primary competitor today, but its platform decisions shape Fasteris' product roadmap and could expand downstream into services.
• LGC Biosearch Technologies: Genomics services and products arm of LGC Group, providing sequencing, genotyping, and custom oligonucleotide services. Broader portfolio than Fasteris but overlapping in NGS and Sanger sequencing offerings for life science customers.

Regional players

• Microsynth: Swiss-based DNA sequencing and synthesis services provider headquartered near Fasteris. A direct regional competitor in Sanger and NGS services, sharing the Swiss quality reputation and overlapping academic/biotech customer base in Switzerland and nearby markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks2 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fasteris-sa

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about fasteris